Takehiko Mori

Author PubWeight™ 57.08‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Related transplantation with HLA-1 Ag mismatch in the GVH direction and HLA-8/8 allele-matched unrelated transplantation: a nationwide retrospective study. Blood 2011 1.65
2 The role of hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma. Am J Hematol 2014 1.40
3 Risk-adapted preemptive therapy for cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation. Int J Hematol 2005 1.39
4 Comparison of unrelated cord blood transplantation and HLA-mismatched unrelated bone marrow transplantation for adults with leukemia. Biol Blood Marrow Transplant 2011 1.10
5 Magnetoresistance effects evidencing the pi-d interaction in metallic organic conductors, (EDT-DSDTFVO)2*MX4 (M = Fe, Ga; X = Cl, Br). Inorg Chem 2006 1.07
6 The first proton-conducting metallic ion-radical salts. Angew Chem Int Ed Engl 2004 1.06
7 Periductal area as the primary site for T-cell activation in lacrimal gland chronic graft-versus-host disease. Invest Ophthalmol Vis Sci 2003 1.05
8 Increase of bone marrow-derived secretory lineage epithelial cells during regeneration in the human intestine. Gastroenterology 2005 1.05
9 Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy. Support Care Cancer 2012 1.03
10 Central nervous system relapse of leukemia after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2008 1.02
11 Antiferromagnetic or canted antiferromagnetic orderings of Fe(III) d spins of FeX4- ions in BEDT-TTFVO(S).FeX4 (X = Cl, Br) [BEDT-TTFVO(S) = bis(ethylenedithio)tetrathiafulvalenoquinone(-thioquinone)-1,3-dithiolemethide]. Inorg Chem 2007 1.01
12 Gelatinous degeneration in a recipient of allogeneic bone marrow transplantation. Int J Hematol 2006 1.00
13 Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders. Biol Blood Marrow Transplant 2007 0.99
14 Spontaneous lacrimal punctal occlusion associated with ocular chronic graft-versus-host disease. Curr Eye Res 2007 0.96
15 Effect of blood cyclosporine concentration on the outcome of hematopoietic stem cell transplantation from an HLA-matched sibling donor. Am J Hematol 2006 0.94
16 Human herpesvirus 6 meningoencephalitis in allogeneic hematopoietic stem cell transplant recipients. Int J Hematol 2006 0.94
17 Oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients. Support Care Cancer 2005 0.94
18 Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and Marrow Transplantation. Br J Haematol 2013 0.92
19 Comparison of stem cell sources in the severity of dry eye after allogeneic haematopoietic stem cell transplantation. Br J Ophthalmol 2011 0.91
20 Clinical factors predicting the response of acute graft-versus-host disease to corticosteroid therapy: an analysis from the GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 2013 0.91
21 Clostridium subterminale septicemia in a recipient of allogeneic cord blood transplantation. Intern Med 2003 0.90
22 Feasibility of reduced-intensity cord blood transplantation as salvage therapy for graft failure: results of a nationwide survey of adult patients. Biol Blood Marrow Transplant 2010 0.90
23 Chryseobacterium meningosepticum septicemia in a recipient of allogeneic cord blood transplantation. Scand J Infect Dis 2004 0.90
24 Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia: a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry. Int J Hematol 2010 0.89
25 Unrelated allogeneic bone marrow-derived mesenchymal stem cells for steroid-refractory acute graft-versus-host disease: a phase I/II study. Int J Hematol 2013 0.89
26 Angiotensin II type 1 receptor antagonist attenuates lacrimal gland, lung, and liver fibrosis in a murine model of chronic graft-versus-host disease. PLoS One 2013 0.88
27 Stabilization of organic field-effect transistors by tert-butyl groups in dibenzotetrathiafulvalene derivatives. Phys Chem Chem Phys 2011 0.87
28 Safety and efficacy of linezolid in 16 infants and children in Japan. J Infect Chemother 2012 0.86
29 Variable magnitude of drug interaction between oral voriconazole and cyclosporine A in recipients of allogeneic hematopoietic stem cell transplantation. Clin Transplant 2012 0.86
30 Allogeneic stem cell transplantation for adult Philadelphia chromosome-negative acute lymphocytic leukemia: comparable survival rates but different risk factors between related and unrelated transplantation in first complete remission. Blood 2010 0.85
31 Development of varicella after allogeneic cord blood transplantation in a varicella zoster virus seropositive patient. Scand J Infect Dis 2008 0.84
32 Successful treatment of extramedullary blast crisis of chronic myelogenous leukemia with imatinib mesylate (STI571). Intern Med 2003 0.83
33 Validation of NIH consensus criteria for diagnosis and severity-grading of chronic graft-versus-host disease. Int J Hematol 2013 0.83
34 Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population. Int J Hematol 2011 0.83
35 Blood eosinophilia as a marker of favorable outcome after allogeneic stem cell transplantation. Transpl Int 2007 0.83
36 Stable metallic behavior and antiferromagnetic ordering of Fe(III) d spins in (EDO-TTFVO)2.FeCl4. J Am Chem Soc 2005 0.81
37 Hemorrhagic colonic ulcers caused by dasatinib for chronic myelogenous leukemia. Int J Hematol 2010 0.80
38 A metallic (EDT-DSDTFVSDS)2.FeBr4 salt: antiferromagnetic ordering of d spins of FeBr4- ions and anomalous magnetoresistance due to preferential pi-d interaction. J Am Chem Soc 2006 0.80
39 Production of anti-ABO blood group antibodies after minor ABO-incompatible bone marrow transplantation in NOD/SCID/gamma(c)(null) mice. Clin Transplant 2013 0.79
40 Successful management of liver injury caused by imatinib mesylate in a patient with previously untreated chronic myelogenous leukemia in the chronic phase. Leuk Lymphoma 2006 0.79
41 A case-control study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation. Transpl Int 2013 0.79
42 Possible involvement of allogeneic antigens recognised by donor-derived CD4 cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy. Br J Haematol 2006 0.79
43 Comparative analysis of clinical outcomes after allogeneic bone marrow transplantation versus peripheral blood stem cell transplantation from a related donor in Japanese patients. Br J Haematol 2004 0.78
44 [Sodium-losing nephropathy caused by tacrolimus after allogeneic hematopoietic stem cell transplantation]. Rinsho Ketsueki 2013 0.78
45 Overcoming the effect of rifampin on the tacrolimus metabolism by itraconazole administration in an allogeneic hematopoietic stem cell transplant recipient. Int J Hematol 2010 0.78
46 Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor. Int J Hematol 2010 0.78
47 Recurrence of autoimmune disease after autologous peripheral blood stem cell transplantation for multiple myeloma. Int J Hematol 2006 0.78
48 Esophageal varices and portal hypertensive gastropathy associated with hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation. Int J Hematol 2008 0.78
49 Effects of immunosuppressive agents on magnesium metabolism early after allogeneic hematopoietic stem cell transplantation. Transplantation 2005 0.78
50 Colon neoplastic cells do not originate from bone marrow-derived cells after sex-mismatched bone marrow transplantation. Anticancer Res 2012 0.77
51 Erythroid crisis caused by parvovirus B19 transmitted via red blood cell transfusion. Intern Med 2011 0.77
52 [Recurrent cellulitis due to Helicobacter cinaedi after chemotherapy for malignant lymphoma]. Rinsho Ketsueki 2012 0.77
53 Oral ribavirin therapy for lower respiratory tract infection of respiratory syncytial virus complicating bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. Int J Hematol 2011 0.77
54 Non-tuberculous mycobacterial infection localized in small intestine developing after allogeneic bone marrow transplantation. Intern Med 2010 0.77
55 Granisetron plus dexamethasone versus granisetron alone in the prevention of vomiting induced by conditioning for stem cell transplantation: a prospective randomized study. Int J Hematol 2003 0.77
56 Hemorrhagic cystitis caused by adenovirus type 34 after allogeneic bone marrow transplantation. Transplantation 2005 0.77
57 Long-term follow-up of reduced-intensity allogeneic hematopoietic stem cell transplantation for refractory or relapsed follicular lymphoma. Am J Hematol 2012 0.77
58 Conducting organic frameworks based on a main-group metal and organocyanide radicals. Chemistry 2013 0.77
59 A high-conductivity crystal containing a copper(I) coordination polymer bridged by the organic acceptor tanc. Angew Chem Int Ed Engl 2006 0.77
60 Structural transitions from triangular to square molecular arrangements in the quasi-one-dimensional molecular conductors (DMEDO-TTF)2XF6 (X = P, As, and Sb). J Am Chem Soc 2012 0.76
61 The recipient CXCL10 + 1642C>G variation predicts survival outcomes after HLA fully matched unrelated bone marrow transplantation. Clin Immunol 2012 0.76
62 Greater impact of oral fluconazole on drug interaction with intravenous calcineurin inhibitors as compared with intravenous fluconazole. Eur J Clin Pharmacol 2007 0.75
63 Reduced-dose cyclophosphamide in combination with fludarabine and anti-thymocyte globulin as a conditioning regimen for allogeneic hematopoietic stem cell transplantation for aplastic anemia. Int J Hematol 2014 0.75
64 Discrepancy in the kinetics of total and active anti-thymocyte globulin blood concentrations in recipients of allogeneic hematopoietic stem cell transplantation. Int J Hematol 2011 0.75
65 Cutaneous aspergillosis in a patient with follicular lymphoma. Eur J Dermatol 2003 0.75
66 Acute renal failure caused by intravenous acyclovir for disseminated varicella zoster virus infection. Scand J Infect Dis 2007 0.75
67 A highly conducting organic metal derived from an organic-transistor material: benzothienobenzothiophene. Phys Chem Chem Phys 2013 0.75
68 [Copper deficiency anemia morphologically mimicking myelodysplastic syndrome]. Rinsho Ketsueki 2014 0.75
69 Ferromagnetic anomaly associated with the antiferromagnetic transitions in (donor)[Ni(mnt)2]-type charge-transfer salts. Inorg Chem 2004 0.75
70 Administration of imatinib mesylate in patients with chronic myeloid leukemia with short bowel. Leuk Lymphoma 2009 0.75
71 Efficacy of aprepitant in preventing nausea and vomiting due to high-dose melphalan-based conditioning for allogeneic hematopoietic stem cell transplantation. Int J Hematol 2014 0.75
72 Hypotension due to the drug interaction of voriconazole with eplerenone and nifedipine. Eur J Clin Pharmacol 2008 0.75
73 Hypersensitivity to fludrocortisone acetate in a recipient of bone marrow transplantation. Allergol Int 2011 0.75
74 [Retrospective analysis of posterior reversible encephalopathy syndrome after allogeneic stem cell transplantation]. Rinsho Ketsueki 2009 0.75
75 [Successful bone marrow transplantation with a matched unrelated donor in an acute promyelocytic leukemia patient after reinduction therapy with arsenic trioxide]. Rinsho Ketsueki 2004 0.75
76 Unfavorable outcome of chronic myelogenous leukemia in adolescent and young adults treated with tyrosine kinase inhibitors. Int J Hematol 2015 0.75
77 Recipient PTPN22 -1123 C/C genotype predicts acute graft-versus-host disease after HLA fully matched unrelated bone marrow transplantation for hematologic malignancies. Biol Blood Marrow Transplant 2012 0.75
78 Allogeneic haematopoietic cell transplantation with reduced-intensity conditioning for elderly patients with advanced myelodysplastic syndromes: a nationwide study. Br J Haematol 2014 0.75
79 Characteristics and fabrication of vertical type organic light emitting transistor using dimethyldicyanoquinonediimine (DMDCNQI) as a n-type active layer and light emitting polymer. J Nanosci Nanotechnol 2011 0.75
80 Demodicidosis as a cause of facial eruption developing early after allogeneic hematopoietic stem cell transplantation. Transpl Int 2008 0.75
81 Cellulitis due to Achromobacter xylosoxidans during bortezomib therapy for multiple myeloma. Rinsho Ketsueki 2016 0.75
82 Detection of leukemia associated antigen-specific cytotoxic T cells in a patient with Philadelphia chromosome-positive leukemia during treatment with dasatinib. Leuk Lymphoma 2013 0.75
83 [Allogeneic hematopoietic stem cell transplantation with fludarabine, melphalan, and total body irradiation as a conditioning for elderly patients with myeloid malignancies]. Rinsho Ketsueki 2012 0.75
84 [Localized recurrence of acute lymphoblastic leukemia-L3 in the tonsil after 3-years' remission]. Rinsho Ketsueki 2002 0.75
85 Acinetobacter lwoffii septicemia associated with a peripheral intravascular catheter. Intern Med 2006 0.75
86 Systemic infection due to Acremonium after allogeneic peripheral blood stem cell transplantation. Intern Med 2006 0.75
87 Interlayer charge disproportionation in the layered organic superconductor κ(H)-(DMEDO-TSeF)2[Au(CN)4](THF) with polar dielectric insulating layers. Phys Rev Lett 2012 0.75
88 Rapid proliferation of a different clone early after autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma. Int J Hematol 2002 0.75
89 Tacrolimus-azithromycin interaction in a recipient of allogeneic bone marrow transplantation. Transpl Int 2005 0.75
90 [Early onset of paralytic ileus caused by simultaneous administration of bortezomib and azole antifungals in multiple myeloma patients]. Rinsho Ketsueki 2012 0.75
91 Successful treatment of bone marrow transplant--associated thrombotic microangiopathy with antithrombin-III. Am J Med 2002 0.75
92 [Post-transplant infectious diseases]. Rinsho Ketsueki 2014 0.75
93 Current-induced metallic state in an organic (EDT-TSF)2GaCl4 conductor. J Am Chem Soc 2006 0.75
94 [Fatal disseminated toxoplasmosis after unrelated bone marrow transplantation for myelodysplastic syndrome]. Rinsho Ketsueki 2012 0.75
95 [Hydroxyurea (hydroxycarbamide)-induced hepatic dysfunction confirmed by drug-induced lymphocyte stimulation test]. Rinsho Ketsueki 2014 0.75
96 Evaluation of safety and efficacy of transjugular liver biopsy in allogeneic hematopoietic stem cell transplant recipients. Rinsho Ketsueki 2014 0.75
97 Bacteremia due to Capnocytophaga species during chemotherapy-induced neutropenia in patients with hematological malignancies. Rinsho Ketsueki 2017 0.75
98 Long-term follow-up of allogeneic bone marrow transplantation after reduced-intensity conditioning in patients with chronic myelogenous leukemia in the chronic phase. Int J Hematol 2002 0.75
99 A flare-up of chronic graft-versus-host disease of the liver that mimics acute hepatitis in a recipient of an allogeneic peripheral blood stem cell transplant. Int J Hematol 2005 0.75
100 A new organic superconductor beta-(meso-DMBEDT-TTF)2PF6. Chem Commun (Camb) 2004 0.75
101 [Second transplantation for graft failure after allogeneic hematopoietic stem cell transplantation--a retrospective survey by Kanto Study Group for Cell Therapy]. Rinsho Ketsueki 2010 0.75
102 [Bacteremia due to Rothia mucilaginosa after chemotherapy for myeloid malignancies]. Rinsho Ketsueki 2015 0.75
103 [Conditioning regimen of allogeneic hematopoietic stem cell transplantation for aplastic anemia in Japan]. Rinsho Ketsueki 2011 0.75
104 Central line-associated bacteremia caused by drug-resistant Staphylococcus caprae after chemotherapy for acute myelogenous leukemia. Int J Hematol 2010 0.75
105 Multiple sclerosis associated with interferon-alpha therapy for chronic myelogenous leukemia. Am J Hematol 2002 0.75
106 Effect of graft sources on allogeneic hematopoietic stem cell transplantation outcome in adults with chronic myeloid leukemia in the era of tyrosine kinase inhibitors: a Japanese Society of Hematopoietic Cell Transplantation retrospective analysis. Int J Hematol 2014 0.75
107 [Successful treatment with L-asparaginase-based combination chemotherapy for refractory T-cell post-transplant lymphoproliferative disorder]. Rinsho Ketsueki 2007 0.75
108 Cicatricial pemphigoid of the oropharynx after allogeneic stem cell transplantation for relapsed follicular lymphoma. Int J Hematol 2005 0.75